Welcome back to Vet Sessions! In this episode, we’re joined by two members of the OVC Clinical Pet Nutrition team to explore the latest updates in feline and canine obesity. Dr. Hannah Godfrey, a post-doctoral fellow, and Shawna Morrow, who has been part of the OVC Pet Nutrition Team for five years and is currently completing her PhD on weight loss in dogs, share insights from emerging research and clinical practice. Tune in as we discuss new findings, practical strategies, and what these advances mean for improving the health and longevity of our companion animals. To learn more about ongoing clinical studies and updates from the OVC Pet Nutrition team, follow them on Instagram @ovcpetnutrition. We hope you enjoy listening!

This week on Vet Sessions, we chat with Dr. Lindsay Ormesher, who is completing her residency in Internal Medicine. Dr. Ormesher talks all about feline infectious peritonitis (FIP) and the latest treatment updates. She shares her firsthand experiences treating what was once considered a fatal disease and achieving truly remarkable outcomes. We discuss how to obtain the medication, how dosing is adjusted throughout treatment, and how these steps can give affected cats the best possible fighting chance. We also highlight BOVA, the manufacturer of this medication, which offers excellent educational resources for veterinarians and pet owners alike. We hope you enjoy this very informative episode!

In this episode of Vet Sessions, we’re joined once again by Dr. Andrew Peregrine, who has had many previous appearances on the show. This time, we discuss the upcoming elimination of Immiticide (Melarsomine) outside of the USA and what this means for heartworm treatment moving forward. Dr. Peregrine shares insights into alternative heartworm treatment options that will be critical once Immiticide is no longer available outside of the USA. As always, his expertise brings valuable perspective to this important topic, and we encourage listeners to check out his past episodes on Vet Sessions as well.